These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
463 related items for PubMed ID: 21969708
1. MRI findings of cancers preoperatively diagnosed as pure DCIS at core needle biopsy. Huang YT, Cheung YC, Lo YF, Ueng SH, Kuo WL, Chen SC. Acta Radiol; 2011 Dec 01; 52(10):1064-8. PubMed ID: 21969708 [Abstract] [Full Text] [Related]
2. Ductal carcinoma in situ: is there a role for MRI? Zuiani C, Francescutti GE, Londero V, Zunnui I, Bazzocchi M. J Exp Clin Cancer Res; 2002 Sep 01; 21(3 Suppl):89-95. PubMed ID: 12585661 [Abstract] [Full Text] [Related]
3. The clinical significance of breast MRI in the management of ductal carcinoma in situ diagnosed on needle biopsy. Miyashita M, Amano G, Ishida T, Tamaki K, Uchimura F, Ono T, Yajima M, Kuriya Y, Ohuchi N. Jpn J Clin Oncol; 2013 Jun 01; 43(6):654-63. PubMed ID: 23592884 [Abstract] [Full Text] [Related]
4. Positive enhancement integral values in dynamic contrast enhanced magnetic resonance imaging of breast carcinoma: ductal carcinoma in situ vs. invasive ductal carcinoma. Nadrljanski M, Maksimović R, Plešinac-Karapandžić V, Nikitović M, Marković-Vasiljković B, Milošević Z. Eur J Radiol; 2014 Aug 01; 83(8):1363-7. PubMed ID: 24894697 [Abstract] [Full Text] [Related]
7. MR features to suggest microinvasive ductal carcinoma of the breast: can it be differentiated from pure DCIS? Hahn SY, Han BK, Ko EY, Shin JH, Hwang JY, Nam M. Acta Radiol; 2013 Sep 01; 54(7):742-8. PubMed ID: 23588154 [Abstract] [Full Text] [Related]
11. Background parenchymal signal enhancement ratio at preoperative MR imaging: association with subsequent local recurrence in patients with ductal carcinoma in situ after breast conservation surgery. Kim SA, Cho N, Ryu EB, Seo M, Bae MS, Chang JM, Moon WK. Radiology; 2014 Mar 01; 270(3):699-707. PubMed ID: 24126372 [Abstract] [Full Text] [Related]
13. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ. Huo L, Sneige N, Hunt KK, Albarracin CT, Lopez A, Resetkova E. Cancer; 2006 Oct 15; 107(8):1760-8. PubMed ID: 16977650 [Abstract] [Full Text] [Related]
14. Can breast MRI computer-aided detection (CAD) improve radiologist accuracy for lesions detected at MRI screening and recommended for biopsy in a high-risk population? Arazi-Kleinman T, Causer PA, Jong RA, Hill K, Warner E. Clin Radiol; 2009 Dec 15; 64(12):1166-74. PubMed ID: 19913125 [Abstract] [Full Text] [Related]
18. Preoperatively diagnosed ductal cancers in situ of the breast presenting as even small masses are of high risk for the invasive cancer foci in postoperative specimen. Szynglarewicz B, Kasprzak P, Halon A, Matkowski R. World J Surg Oncol; 2015 Jul 16; 13():218. PubMed ID: 26179898 [Abstract] [Full Text] [Related]
19. Targeting difficult accessible breast lesions: MRI-guided needle localization using a freehand technique in a 3.0 T closed bore magnet. Meeuwis C, Peters NH, Mali WP, Gallardo AM, van Hillegersberg R, Schipper ME, van den Bosch MA. Eur J Radiol; 2007 May 16; 62(2):283-8. PubMed ID: 17218074 [Abstract] [Full Text] [Related]